×
Log in
Upload File
Most Popular
Study
Business
Design
Technology
Travel
Explore all categories
The top documents tagged [efv group]
IAS 2011_ Abstract # WEPDB0102 Sustained Efficacy and Tolerability of Raltegravir after 240 Weeks of Combination ART in Treatment- Naive HIV-1 Infected
216 views
Background TMC278, a next-generation NNRTI, has demonstrated in-vitro activity against wild-type and NNRTI-resistant isolates 1 48-week results from an
214 views
Background
20 views